| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.09 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |